Catheter Precision (VTAK) Expected to Announce Earnings on Thursday

Catheter Precision (NYSEAMERICAN:VTAK) is expected to post its quarterly earnings results on Thursday, March 27th. Analysts expect Catheter Precision to post earnings of ($0.20) per share and revenue of $0.28 million for the quarter.

Catheter Precision Trading Down 6.2 %

Shares of VTAK opened at $0.39 on Tuesday. The company has a quick ratio of 0.65, a current ratio of 0.66 and a debt-to-equity ratio of 0.12. Catheter Precision has a 12 month low of $0.30 and a 12 month high of $8.40. The firm’s fifty day simple moving average is $0.41.

Catheter Precision Company Profile

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.